Cai-Yun Wang
Cai-Yun Wang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Pok Eric Yang
Inti Labs, Hsinchu 302, Taiwan
2 shared publications - Tiffany Wang
Inti Labs, Hsinchu 302, Taiwan
2 shared publications - An Hsu
Inti Labs, Hsinchu 302, Taiwan
1 shared publication - Chun-I Lee
School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan; Division of Infertility, Lee Women's Hospital, Taichung 40652, Taiwan; Department of Obstetrics and Gynecology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
1 shared publication - Chung-I Chen
Division of Infertility, Lee Women’s Hospital, Taichung 40402, Taiwan
1 shared publication - En-Hui Cheng
Genetic Diagnosis Laboratory, Lee Women’s Hospital, Taichung 40652, Taiwan
1 shared publication
Latest Publications
- Open Access
- 31 October 2025
- Published by MDPI AG in Preprints.org
The Dynamic Change of microRNA Expression Profile in Endometrium and Plasma During the Periimplantation Window
Background: MicroRNAs (miRNAs) regulate gene expression critical for embryo implan-tation, but integrated analyses of miRNA changes in both endometrium and plasma dur-ing the peri-implantation period are lacking. Methods: A total of 62 endometrium and 62 plasma samples were collected from participants undergoing hormone treatment cycles between day P+3 to P+7. Next-generation sequencing (NGS) assay was used to profile miRNA expression levels. To identify the dynamic differentially expressed (DE) miRNAs, we compared the following groups: P+3/P+4, P+4/P+5, P+5/P+6, and P+6/P+7. Then, we perform functional miRNA-target interaction (MTI) and pathway enrichment analysis to understand the biological functions of DE miRNAs. Results: A total of 76 DE miRNAs in endometrium and 48 in plasma were identified. These miRNAs are involved in pathways related to implantation, such as cell senescence, cell growth, apoptosis, focal adhesion, autophagy, platelet activation and signaling. Ten DE miRNAs overlapped between en-dometrial tissue and plasma, with seven showing consistent dynamic expression changes. Further analysis revealed a high similarity in the biological pathways and functions in-volving the target genes of DE miRNAs in both endometrium and plasma. Conclusions: Dynamic miRNA expression changes in both endometrium and plasma reflect key bio-logical processes regulating human embryo implantation.
- 31 October 2025
- Published by MDPI AG in Preprints.org
Open AccessThe Dynamic Change of microRNA Expression Profile in Endometrium and Plasma During the Periimplantation Window
Background: MicroRNAs (miRNAs) regulate gene expression critical for embryo implan-tation, but integrated analyses of miRNA changes in both endometrium and plasma dur-ing the peri-implantation period are lacking. Methods: A total of 62 endometrium and 62 plasma samples were collected from participants undergoing hormone treatment cycles between day P+3 to P+7. Next-generation sequencing (NGS) assay was used to profile miRNA expression levels. To identify the dynamic differentially expressed (DE) miRNAs, we compared the following groups: P+3/P+4, P+4/P+5, P+5/P+6, and P+6/P+7. Then, we perform functional miRNA-target interaction (MTI) and pathway enrichment analysis to understand the biological functions of DE miRNAs. Results: A total of 76 DE miRNAs in endometrium and 48 in plasma were identified. These miRNAs are involved in pathways related to implantation, such as cell senescence, cell growth, apoptosis, focal adhesion, autophagy, platelet activation and signaling. Ten DE miRNAs overlapped between en-dometrial tissue and plasma, with seven showing consistent dynamic expression changes. Further analysis revealed a high similarity in the biological pathways and functions in-volving the target genes of DE miRNAs in both endometrium and plasma. Conclusions: Dynamic miRNA expression changes in both endometrium and plasma reflect key bio-logical processes regulating human embryo implantation.
- Open Access
- 25 March 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (7) , 3670
Different Dosages of Progesterone in Luteal Phase Support Reflect Varying Endometrial microRNA Expression in Frozen Embryo Transfer Cycles
Despite serum progesterone being a widely accepted method for luteal phase support during embryo transfer cycles, debates persist regarding the optimal strategy for guiding clinical decisions on progesterone dosages to maximize reproductive outcomes. This retrospective study explored the utility of microRNA (miRNA) biomarkers in guiding personalized progesterone dosage adjustments for frozen embryo transfer (FET) cycles in 22 in vitro fertilization (IVF) patients undergoing hormone replacement therapy. Utilizing MIRA, an miRNA-based endometrial receptivity test, we analyzed patients’ miRNA expression profiles before and after progesterone dosage adjustments to determine suitable dosages and assess endometrial status. Despite patients receiving identical progesterone dosages, variations in miRNA profiles were observed in the initial cycle, and all patients presented a displaced window of implantation. Following dosage adjustments based on their miRNA profiles, 91% of patients successfully transitioned their endometrium towards the receptive stages. However, two patients continued to exhibit persistent displaced receptivity despite the adjustments. Given the evident variation in endometrial status and serum progesterone levels among individuals, analyzing miRNA expression profiles may address the challenge of inter-personal variation in serum progesterone levels, to deliver more personalized dosage adjustments and facilitate personalized luteal phase support in IVF.
- 25 March 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (7) , 3670
Open AccessDifferent Dosages of Progesterone in Luteal Phase Support Reflect Varying Endometrial microRNA Expression in Frozen Embryo Transfer Cycles
Despite serum progesterone being a widely accepted method for luteal phase support during embryo transfer cycles, debates persist regarding the optimal strategy for guiding clinical decisions on progesterone dosages to maximize reproductive outcomes. This retrospective study explored the utility of microRNA (miRNA) biomarkers in guiding personalized progesterone dosage adjustments for frozen embryo transfer (FET) cycles in 22 in vitro fertilization (IVF) patients undergoing hormone replacement therapy. Utilizing MIRA, an miRNA-based endometrial receptivity test, we analyzed patients’ miRNA expression profiles before and after progesterone dosage adjustments to determine suitable dosages and assess endometrial status. Despite patients receiving identical progesterone dosages, variations in miRNA profiles were observed in the initial cycle, and all patients presented a displaced window of implantation. Following dosage adjustments based on their miRNA profiles, 91% of patients successfully transitioned their endometrium towards the receptive stages. However, two patients continued to exhibit persistent displaced receptivity despite the adjustments. Given the evident variation in endometrial status and serum progesterone levels among individuals, analyzing miRNA expression profiles may address the challenge of inter-personal variation in serum progesterone levels, to deliver more personalized dosage adjustments and facilitate personalized luteal phase support in IVF.